Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells

PaperCitations, authors & open-access status

EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 59 citations, 2022 year and gold oa status.

59
Citations
2022
Year
gold
OA Status

Related on ScholarIQ

Yoshimasa Suzuki
Author
Scientific Reports
Journal
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Hepatocellular Carcinoma Treatment and Prognosis
Topic
Lung Cancer Treatments and Mutations
Topic
PI3K/AKT/mTOR signaling in cancer
Topic
470M+ articles · free account